Skip Navigation



Human Molecular Genetics Advance Access published online on February 10, 2009

Human Molecular Genetics, doi:10.1093/hmg/ddp069
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
18/9/1578    most recent
ddp069v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Park, J.-S.
Right arrow Articles by Bai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, J.-S.
Right arrow Articles by Bai, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis

Jeong-Soon Park1, Lokendra Kumar Sharma1, Hong-Zhi Li2, Ruihua Xiang1, Deborah Holstein1, Jun Wu1, James Lechleiter1, Susan L. Naylor1, Janice Deng1, Jianxin Lu2 and Yidong Bai1,2,*

1 Department of Cellular and Structural Biology, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas 78229, USA 2 Wenzhou Medical College, Wenzhou 325035, China

* Corresponding author: Yidong Bai, PhD, Department of Cellular and Structural Biology, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas 78229 Telephone: (210)-567-0561 Fax: (210)-567-3803 E-mail: baiy{at}uthscsa.edu

Received December 18, 2008; Revised January 16, 2009; Accepted February 4, 2009

Mitochondrial alteration has been long proposed to play a major role in tumorigenesis. Recently, mitochondrial DNA (mtDNA) mutations have been found in a variety of cancer cells. In this study, we examined the contribution of mtDNA mutation and mitochondrial dysfunction in tumorigenesis first using human cell lines carrying a frame-shift at NADH dehydrogenase (respiratory complex I) subunit 5 gene (ND5); the same homoplasmic mutation was also identified in a human colorectal cancer cell line earlier. With increasing mutant ND5 mtDNA content, respiratory function including oxygen consumption and ATP generation through oxidative phosphorylation declined progressively, while lactate production and dependence on glucose increased. Interestingly, the reactive oxygen species (ROS) levels and apoptosis exhibited antagonistic pleiotropy associated with mitochondrial defects. Further more, the anchorage dependence phenotype and tumor-forming capacity of cells carrying wild-type and mutant mtDNA were tested by growth assay in soft agar and subcutaneous implantation of the cells in nude mice. Surprisingly, the cell line carrying the heteroplasmic ND5 mtDNA mutation showed significantly enhanced tumor growth, while cells with homoplasmic form of the same mutation inhibited tumor formation. Similar results were obtained from the analysis of a series of mouse cell lines carrying a nonsense mutation at ND5 gene. Our results indicate that the mtDNA mutations might play an important role in early stage of cancer development, possibly through alteration of ROS generation and apoptosis.


The authors wish it to be known that the first two authors should be considered the joint first authors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. Koshikawa, J.-I. Hayashi, A. Nakagawara, and K. Takenaga
Reactive Oxygen Species-generating Mitochondrial DNA Mutation Up-regulates Hypoxia-inducible Factor-1{alpha} Gene Transcription via Phosphatidylinositol 3-Kinase-Akt/Protein Kinase C/Histone Deacetylase Pathway
J. Biol. Chem., November 27, 2009; 284(48): 33185 - 33194.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.